Palena Therapeutics
UEI: WRWDJ3LHZLN5
• CAGE: 9U7E2
Overview
Awardee Type
Parent
Company Description
Explore our groundbreaking research on immunomodulatory peptides and their potential to revolutionize multiple sclerosis treatment. Learn how these peptides can modulate the immune system and provide targeted therapy.
Name
Palena Therapeutics
Website
Headquarters
Worcester, MA
United States
United States
Most Recent Award
March 1, 2025
Calculating
Federal grant recipient
PALENA THERAPEUTICS, INC.
(UEI WRWDJ3LHZLN5, CAGE 9U7E2)
is headquartered in Worcester MA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in January 2020 and
federally registered in
November 2023.
Federal Award Analysis
Palena Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PALENA THERAPEUTICS, INC.
UEI
WRWDJ3LHZLN5
CAGE Code
9U7E2
SBA Certifications
None
Self Certifications
Woman Owned Business
Woman Owned Small Business
Woman Owned Small Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 13, 2020
Initial Registration
Nov. 30, 2023
Last Registration
Dec. 26, 2024
Registration Activation
Dec. 26, 2024
Registration Expiration
Dec. 26, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No